Amy D Dobberfuhl
Overview
Explore the profile of Amy D Dobberfuhl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dobberfuhl A
Neurourol Urodyn
. 2022 May;
41(8):1958-1966.
PMID: 35607890
Introduction: Interstitial cystitis/bladder pain syndrome (IC/BPS) is prevalent, difficult to treat, and has close symptom overlap with overactive bladder (OAB). A review of the pathophysiology, assessment, and treatment of IC/BPS...
12.
Zhang X, Shaffer R, Dobberfuhl A
Investig Clin Urol
. 2021 Aug;
62(5):584-591.
PMID: 34387039
Purpose: To improve counseling in women at risk of refractory and/or urgency urinary incontinence (UUI) following sling placement at time of prolapse repair, we created an outcome model to characterize...
13.
Dobberfuhl A, van Uem S, Versi E
Int Urogynecol J
. 2021 Jun;
32(12):3105-3111.
PMID: 34156506
The pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS) may be bladder-centric, with afferent nerve hyperexcitability and/or due to neural central sensitization. In bladder-centric disease, the trigone's unmyelinated nociceptive C-fibers are...
14.
Dobberfuhl A, Schuler C, Leggett R, De E, Levin R
Investig Clin Urol
. 2020 Jul;
61(4):432-440.
PMID: 32666001
Purpose: To explore the effect of estrogen replacement on pelvic floor and bladder contractile response to electrical field stimulation, following hypoxia in an animal model of surgical menopause. Materials And...
15.
Diaz E, Briggs M, Wen Y, Zhuang G, Wallace S, Dobberfuhl A, et al.
BMC Urol
. 2020 Apr;
20(1):44.
PMID: 32321501
Background: Relaxin is an endogenous protein that has been shown to have antifibrotic properties in various organ systems. There has been no characterization of relaxin's role in the human bladder....
16.
Dobberfuhl A, Zhang X, Comiter C
Int Urol Nephrol
. 2019 Nov;
52(2):239-246.
PMID: 31673936
Purpose: To identify urodynamic factors associated with the mechanical stop test and immediate spontaneous voiding following transurethral resection of prostate (TURP). Methods: We identified 90 men who underwent TURP over...
17.
Dobberfuhl A, Chen A, Alkaram A, De E
Neurourol Urodyn
. 2019 Aug;
38(8):2224-2232.
PMID: 31432550
Aims: To identify clinical and urodynamic factors leading to spontaneous voiding in men with detrusor underactivity (DU) and suspected bladder outlet obstruction who underwent an outlet de-obstruction procedure. Methods: We...
18.
Dobberfuhl A, Shaffer R, Goodman S, Chen B
Neurourol Urodyn
. 2019 Mar;
38(5):1322-1331.
PMID: 30912192
Aims: To identify the clinical and urodynamic factors associated with the large capacity bladder and incomplete bladder emptying after prolapse repair. Methods: We identified 592 women who underwent anterior and/or...
19.
Shaffer R, Dobberfuhl A, Vu K, Fast A, Dababou S, Marrocchio C, et al.
Am J Obstet Gynecol
. 2019 Feb;
220(5):471.e1-471.e11.
PMID: 30711512
Background: Urinary and pelvic floor symptoms often are attributed to size and location of uterine fibroid tumors. However, direct supporting evidence that links increased size to worsening symptoms is scant...
20.
Syan R, Briggs M, Olivas J, Srivastava S, Comiter C, Dobberfuhl A
Investig Clin Urol
. 2019 Jan;
60(1):40-45.
PMID: 30637360
Purpose: OnabotulinumtoxinA (BTX) detrusor chemodenervation is an efficacious third-line treatment for overactive bladder. Despite high clinical efficacy rates for BTX injection, many patients refuse initial or repeat treatment due to...